Clearance of plasma PCSK9 via the asialoglycoprotein receptor mediated by heterobifunctional ligands-Reference-Cited by-同舟云学术

Clearance of plasma PCSK9 via the asialoglycoprotein receptor mediated by heterobifunctional ligands

Published:2023-01 Issue:1 Volume:30 Page:97-109.e9
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Bagdanoff Jeffrey T.,Smith Thomas M.,Allan Martin,O’Donnell Peter,Nguyen Zachary,Moore Elizabeth A.,Baird Jason,Wang Shuangxi,Subramanian Vanitha,Tigani Bruno,Nettleton David O.,Monovich Lauren G.,Lewis Ian,Flyer Alec N.,Granda Brian,Blankenship John W.,Barnes-Seeman David,Clairmont Kevin B.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference71 articles.

1. A receptor-mediated pathway for cholesterol homeostasis;Brown;Science,1986

2. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia;Abifadel;Nat. Genet.,2003

3. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation;Zhang;J. Biol. Chem.,2007

4. New hypotheses about the structure-function of proprotein convertase subtilisin/kexin type 9: analysis of the epidermal growth factor-like repeat A docking site using WaterMap;Pearlstein;Proteins,2010

5. Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH;Lo Surdo;EMBO Rep.,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted degradation of membrane and extracellular proteins with LYTACs;Acta Pharmacologica Sinica;2024-08-05

2. Targeted Extracellular Protein Degradation by Dendronized DNA Chimeras;ACS Chemical Biology;2024-02-08

3. Targeted degradation of extracellular secreted and membrane proteins;Trends in Pharmacological Sciences;2023-11

4. Targeting PCSK9 to tackle cardiovascular disease;Pharmacology & Therapeutics;2023-09

5. Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment;International Journal of Molecular Sciences;2023-08-21